Drug-Trial News

‘Breakthrough Therapy Designation’ to Novel Schizophrenia Drug- SEP-363856

12 months ago Newsdesk

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for SEP-363856, a novel…

Advertisements

FDA Approves New Oral Testosterone (JATENZO)

12 months ago Newsdesk

.

FDA Adds Stronger Boxed Warnings for Eszopiclone, Zaleplon & Zolpidem

12 months ago Newsdesk

The U.S. Food and Drug Administration today announced the agency is requiring a new boxed…

FDA Approves Brexanolone (ZULRESSO) -First Treatment for Post-Partum Depression

12 months ago Newsdesk

US FDA Approves Brexanolone (ZULRESSO) -First Treatment for Post-Partum Depression The U.S. Food and Drug…

FDA approves esketamine nasal spray SPRAVATO for treatment-resistant depression

12 months ago Newsdesk

The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with…

FDA approves PLENITY— a New Prescription Aid for Weight Loss

12 months ago Newsdesk

Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases…